Wolff Wiese Magana’s GSK GSK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.96K | Hold |
77
| – | – | ﹤0.01% | 657 |
|
|
2025
Q1 | $2.98K | Buy |
77
+73
| +1,825% | +$2.83K | ﹤0.01% | 667 |
|
|
2024
Q4 | $136 | Hold |
4
| – | – | ﹤0.01% | 929 |
|
|
2024
Q3 | $164 | Hold |
4
| – | – | ﹤0.01% | 957 |
|
|
2024
Q2 | $154 | Hold |
4
| – | – | ﹤0.01% | 757 |
|
|
2024
Q1 | $172 | Hold |
4
| – | – | ﹤0.01% | 686 |
|
|
2023
Q4 | $149 | Hold |
4
| – | – | ﹤0.01% | 687 |
|
|
2023
Q3 | $145 | Sell |
4
-32
| -89% | -$1.16K | ﹤0.01% | 762 |
|
|
2023
Q2 | $1.28K | Hold |
36
| – | – | ﹤0.01% | 594 |
|
|
2023
Q1 | $1.28K | Sell |
36
-40
| -53% | -$1.42K | ﹤0.01% | 558 |
|
|
2022
Q4 | $2.67K | Sell |
76
-108
| -59% | -$3.8K | ﹤0.01% | 471 |
|
|
2022
Q3 | $5K | Sell |
184
-226
| -55% | -$6.14K | ﹤0.01% | 606 |
|
|
2022
Q2 | $22K | Buy |
410
+36
| +10% | +$1.93K | 0.02% | 373 |
|
|
2022
Q1 | $20K | Sell |
374
-121
| -24% | -$6.47K | 0.01% | 422 |
|
|
2021
Q4 | $27K | Sell |
495
-37
| -7% | -$2.02K | 0.02% | 371 |
|
|
2021
Q3 | $25K | Buy |
532
+146
| +38% | +$6.86K | 0.02% | 384 |
|
|
2021
Q2 | $19K | Hold |
386
| – | – | 0.01% | 403 |
|
|
2021
Q1 | $17K | Buy |
386
+67
| +21% | +$2.95K | 0.01% | 411 |
|
|
2020
Q4 | $14K | Buy |
+319
| New | +$14K | 0.01% | 404 |
|